We are excited to extend our vision, and we appreciate the continued support given to us by our investors, industry partners, and patients we serve across the country.” The Halodoc technology that powers our Appointment system pre-pandemic is now being used to provide a safe and efficient patient journey for COVID-19 testing and vaccinations. We are also proud to be at the forefront of Indonesia's fight against COVID-19. Today, we provide over 20 million users with convenient and reliable healthcare services monthly. Jonathan Sudharta, Halodoc CEO, said: “Halodoc has grown to be Indonesia’s leading healthtech provider. Halodoc vaccinated over 50,000 citizens across two islands in the first 23 days of the vaccination program, making it one of the country's leading vaccination facilitators. Recently, with Halodoc's proven track record, the Ministry of Health also appointed Halodoc to help roll out Indonesia's national vaccination program. Halodoc was also the first to roll out their drive-thru COVID-19 testing nationwide and become the most prominent operating provider in Indonesia. Halodoc has expanded their appointment service during the pandemic to help Indonesian's book COVID-19 tests and vaccinations.
Despite Indonesia being the world’s fourth most populous country with a population of more than 260 million spread across some 17,000 islands, access to healthcare is still limited for the majority of the population. The funds raised will be used to deepen Halodoc’s penetration in key healthcare verticals across Indonesia, improving patient experiences with technology-based solutions for the country’s most pressing healthcare problems. This is the third major funding round for Halodoc since its establishment in 2016. UOB Venture Management, Singtel Innov8, BliBli, Allianz X, Openspace Ventures, and other existing investors also participated. Other new investors in the financing round include Temasek, Telkomsel’s TMI, Novo Holdings, Acrew Diversify Capital Fund, and Bangkok Bank. Jakarta, 21 April 2021 ─ Halodoc, an Indonesia-based healthtech startup, announced today that it has raised US$80 million in funding, led by new investor, PT Astra Digital Internasional, a subsidiary of PT Astra International Tbk (Astra).
0 kommentar(er)
